ARCHIVES

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NSABP Executive Committee Drops Suit Against Pitt

February 10, 1995

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

November 29, 2002

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991

Freireich, Moertel Matched Up Again

February 20, 1981

New Publications

May 4, 1990

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014